☰

Rex M. Philpot, Ph.D. - Publications

Affiliations: 
Psychiatry and Behavioral Neurosciences University of South Florida, Tampa, FL, United States 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Johns BE, Ficken M, Engberg ME, Wecker L, Philpot RM. Increasing dietary choline attenuates spatial memory deficits resulting from exposure to the chemotherapeutic agents cyclophosphamide and doxorubicin. Journal of Psychopharmacology (Oxford, England). 2698811211029752. PMID 34225528 DOI: 10.1177/02698811211029752  0.55
2019 Philpot RM, Ficken M, Johns BE, Engberg ME, Wecker L. Spatial memory deficits in mice induced by chemotherapeutic agents are prevented by acetylcholinesterase inhibitors. Cancer Chemotherapy and Pharmacology. PMID 31302713 DOI: 10.1007/S00280-019-03881-8  0.568
2017 Wecker L, Marrero-Rosado B, Engberg ME, Johns BE, Philpot RM. 3-Acetylpyridine neurotoxicity in mice. Neurotoxicology. 58: 143-152. PMID 27986589 DOI: 10.1016/J.Neuro.2016.11.010  0.609
2016 Philpot RM, Ficken M, Wecker L. Doxorubicin and cyclophosphamide lead to long-lasting impairment of spatial memory in female, but not male mice. Behavioural Brain Research. 307: 165-175. PMID 27083301 DOI: 10.1016/J.Bbr.2016.04.017  0.591
2016 Schroeder RA, Wecker L, Philpot RM. Obstacles and opportunities for cholinergic drug development in the treatment of cognitive disorders. Current Pharmaceutical Design. PMID 26818870 DOI: 10.2174/1381612822666160127111453  0.567
2016 Schroeder RA, Wecker L, Philpot RM. Obstacles and opportunities for cholinergic drug development in the treatment of cognitive disorders Current Pharmaceutical Design. 22: 1981-1985. DOI: 10.2174/1381612822666160127111453  0.528
2015 Lambert CS, Philpot RM, Engberg ME, Johns BE, Wecker L. Analysis of gait in rats with olivocerebellar lesions and ability of the nicotinic acetylcholine receptor agonist varenicline to attenuate impairments. Behavioural Brain Research. 291: 342-50. PMID 26049061 DOI: 10.1016/J.Bbr.2015.05.056  0.612
2015 Philpot RM. Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits. Neurochemical Research. PMID 25652578 DOI: 10.1007/S11064-015-1528-Y  0.338
2015 Lambert CS, Philpot RM, Engberg ME, Johns BE, Wecker L. Analysis of gait in rats with olivocerebellar lesions and ability of the nicotinic acetylcholine receptor agonist varenicline to attenuate impairments Behavioural Brain Research. 291: 342-350. DOI: 10.1016/j.bbr.2015.05.056  0.567
2014 Lambert CS, Philpot RM, Engberg ME, Johns BE, Kim SH, Wecker L. Gait analysis and the cumulative gait index (CGI): Translational tools to assess impairments exhibited by rats with olivocerebellar ataxia. Behavioural Brain Research. 274: 334-43. PMID 25116252 DOI: 10.1016/J.Bbr.2014.08.004  0.605
2014 Fernandez JW, Grizzell JA, Philpot RM, Wecker L. Postpartum depression in rats: differences in swim test immobility, sucrose preference and nurturing behaviors. Behavioural Brain Research. 272: 75-82. PMID 24983658 DOI: 10.1016/J.Bbr.2014.06.041  0.736
2014 Philpot RM, Engberg ME, Wecker L. Ethanol conditioned place preference and alterations in ΔFosB following adolescent nicotine administration differ in rats exhibiting high or low behavioral reactivity to a novel environment. Behavioural Brain Research. 262: 101-8. PMID 24412683 DOI: 10.1016/J.Bbr.2013.12.014  0.702
2013 Wecker L, Engberg ME, Philpot RM, Lambert CS, Kang CW, Antilla JC, Bickford PC, Hudson CE, Zesiewicz TA, Rowell PP. Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia. Neuropharmacology. 73: 75-86. PMID 23711550 DOI: 10.1016/J.Neuropharm.2013.05.016  0.617
2013 Lambert C, Philpot R, Engberg M, Wecker L. Varenicline ameliorates spatial and temporal gait deficits following 3-acetylpyridine-induced ataxia in rats Biochemical Pharmacology. 86: 1234. DOI: 10.1016/J.Bcp.2013.08.054  0.591
2012 Philpot RM, Engberg ME, Wecker L. Effects of nicotine exposure on locomotor activity and pCREB levels in the ventral striatum of adolescent rats. Behavioural Brain Research. 230: 62-8. PMID 22301350 DOI: 10.1016/J.Bbr.2012.01.036  0.682
2011 Wecker L, Engberg M, Philpot R, Lambert C, Bickford P, Hudson C. Neuronal nicotinic receptor agonists ameliorate 3-acetylpyridine-induced ataxia Biochemical Pharmacology. 82: 1041. DOI: 10.1016/J.Bcp.2011.07.047  0.573
2009 Philpot RM, Wecker L, Kirstein CL. Repeated ethanol exposure during adolescence alters the developmental trajectory of dopaminergic output from the nucleus accumbens septi. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 27: 805-15. PMID 19712739 DOI: 10.1016/J.Ijdevneu.2009.08.009  0.761
2008 Philpot RM, Wecker L. Dependence of adolescent novelty-seeking behavior on response phenotype and effects of apparatus scaling. Behavioral Neuroscience. 122: 861-75. PMID 18729640 DOI: 10.1037/0735-7044.122.4.861  0.653
2004 Stansfield KH, Philpot RM, Kirstein CL. An animal model of sensation seeking: the adolescent rat. Annals of the New York Academy of Sciences. 1021: 453-8. PMID 15251928 DOI: 10.1196/Annals.1308.063  0.77
2004 Philpot R, Kirstein C. Developmental differences in the accumbal dopaminergic response to repeated ethanol exposure. Annals of the New York Academy of Sciences. 1021: 422-6. PMID 15251921 DOI: 10.1196/Annals.1308.056  0.718
2004 Vila JL, Philpot RM, Kirstein CL. Grid crossing: inability to compare activity levels between adolescent and adult rats. Annals of the New York Academy of Sciences. 1021: 418-21. PMID 15251920 DOI: 10.1196/Annals.1308.055  0.684
2004 Torrella TA, Badanich KA, Philpot RM, Kirstein CL, Wecker L. Developmental differences in nicotine place conditioning. Annals of the New York Academy of Sciences. 1021: 399-403. PMID 15251917 DOI: 10.1196/Annals.1308.052  0.734
2003 Philpot RM, Badanich KA, Kirstein CL. Place conditioning: age-related changes in the rewarding and aversive effects of alcohol. Alcoholism, Clinical and Experimental Research. 27: 593-9. PMID 12711921 DOI: 10.1111/J.1530-0277.2003.Tb04395.X  0.75
2001 Philpot RM, McQuown S, Kirstein CL. Stereotaxic localization of the developing nucleus accumbens septi. Brain Research. Developmental Brain Research. 130: 149-53. PMID 11557105 DOI: 10.1016/S0165-3806(01)00225-5  0.694
2000 Bjugstad KB, Flitter WD, Garland WA, Philpot RM, Kirstein CL, Arendash GW. CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-alpha infusion model for AIDS dementia complex. Journal of Neurovirology. 6: 478-91. PMID 11175320 DOI: 10.3109/13550280009091948  0.601
1999 Donovan DM, Miner LL, Perry MP, Revay RS, Sharpe LG, Przedborski S, Kostic V, Philpot RM, Kirstein CL, Rothman RB, Schindler CW, Uhl GR. Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression. Brain Research. Molecular Brain Research. 73: 37-49. PMID 10581396 DOI: 10.1016/S0169-328X(99)00235-1  0.657
1999 Philpot RM, Kirstein CL. Repeated cocaine exposure: effects on catecholamines in the nucleus accumbens septi of periadolescent animals. Pharmacology, Biochemistry, and Behavior. 62: 465-72. PMID 10080238 DOI: 10.1016/S0091-3057(98)00198-1  0.68
1998 Philpot RM, Kirstein CL. The effects of repeated alcohol exposure on the neurochemistry of the periadolescent nucleus accumbens septi. Neuroreport. 9: 1359-63. PMID 9631429 DOI: 10.1097/00001756-199805110-00020  0.718
1997 Kirstein CL, Philpot RM, Dark T. Fetal alcohol syndrome: early olfactory learning as a model system to study neurobehavioral deficits. The International Journal of Neuroscience. 89: 119-32. PMID 9134450 DOI: 10.3109/00207459708988467  0.657
Show low-probability matches.